Hologic to acquire molecular diagnostics firm Biotheranostics for $230m
Hologic, a US-based medical technology company, has agreed to acquire Biotheranostics, a commercial-stage molecular diagnostic company, for about $230m. Biotheranostics is engaged in developing and providing diagnostic, prognostic